CRL up +1.15% percent Today $CRL High is at 64.40 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 3:42 PM

CRL up +1.15% percent Today $CRL High is at 64.40 and the Low 63.29 with current volume of 105,159.

Recent News posted below.

Charles River Laboratories Intl CRL other info.
http://investorshangout.com/Charles-River-Lab...CRL-50619/

CRL Charles River Laboratories Intl Recent Headline News

Charles River Laboratories Earnings In Retrospect: Down 1.7% in the Last 12 Days (CRL)
Comtex SmarTrend(R) - Mon Nov 10, 9:16AM CST
A week ago on October 29th, 2014 Charles River Laboratories (NYSE:CRL) reported earnings and analysts, on average, expected earnings of $0.80 on sales of $326.8 million. The company actually reported EPS of $0.86 on sales of $327.6 million, beating EPS estimates by $0.06 and beating revenue estimates by $0.8 million. Shares of Charles River Laboratories have slipped from $64.47 to $63.36, representing a loss of 1.7%, since the company reported earnings 12 days ago.
CRL: 63.98 (+0.62)

Strength Seen in Covance (CVD): Stock Surges 25.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 8:25AM CST
Covance (CVD) was a big mover last session, with shares surging nearly 26% on the day.
BEAT: 8.20 (+0.05), CRL: 63.98 (+0.62), ICLR: 53.46 (+0.85), CVD: 100.73 (+0.21)

Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX
at The Street - Fri Oct 31, 5:00AM CDT
Cramer says Take-Two Interactive is king of the hill and he's a big fan of Flextronics and its stock buyback program.
FLEX: 10.79 (-0.07), TTWO: 26.22 (+0.06), BIIB: 327.78 (+7.03), GILD: 106.97 (+0.52), CRL: 63.98 (+0.62), REGN: 386.29 (+8.45), CELG: 108.17 (+1.72)

Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14)
SA Editor Miriam Metzinger - Seeking Alpha - Fri Oct 31, 4:46AM CDT
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday October 30. CEO Interview: James Foster, Charles River Labs (NYSE: CRL ) Cramer spoke with James Foster, CEO of Charles River Labs ( CRL ). The company...
FLEX: 10.79 (-0.07), MMM: 157.52 (+0.97), BIIB: 327.78 (+7.03), CLR: 54.54 (-0.59), HON: 97.26 (+0.49), FB: 75.05 (-0.55), DIS: 89.70 (-0.30), BMY: 58.69 (+0.37), CELG: 108.17 (+1.72), SBUX: 77.77 (-0.02), WWAV: 35.83 (-1.10), HAIN: 109.07 (+1.39), UA: 68.48 (+1.50), TTWO: 26.22 (+0.06), RDS.B: 74.25 (-0.19), RDS.A: 70.78 (-0.22), TJX: 63.81 (-0.19), GILD: 106.97 (+0.52), CMG: 648.56 (-0.47), COST: 137.54 (-0.17), BP: 41.90 (-0.16), ARCP: 8.51 (-0.28), CRL: 63.98 (+0.62), AAPL: 108.96 (-0.05), REGN: 386.29 (+8.45), WEN: 8.53 (+0.23)

Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong
at The Street - Thu Oct 30, 7:11PM CDT
The end of quantitative easing was supposed to create a laundry list of problems, Cramer says. It didn't happen.
MMM: 157.52 (+0.97), BIIB: 327.78 (+7.03), HON: 97.26 (+0.49), FB: 75.05 (-0.55), BMY: 58.69 (+0.37), MGM: 22.16 (+0.22), ATK: 110.19 (+1.36), YRCW: 24.39 (+0.42), UPS: 109.11 (+0.78), SLB: 98.47 (-0.26), CELG: 108.17 (+1.72), WPRT: 5.88 (-0.18), SBUX: 77.77 (-0.02), TTWO: 26.22 (+0.06), DO: 37.20 (-1.54), ETP: 65.39 (-0.62), GILD: 106.97 (+0.52), ARR: 3.98 (unch), CMG: 648.56 (-0.47), MPEL: 25.25 (+0.48), WNC: 10.71 (+0.07), CRL: 63.98 (+0.62), AAPL: 108.96 (-0.05), REGN: 386.29 (+8.45)

Charles River Laboratories International's (CRL) CEO James Foster on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 1:50PM CDT

CRL: 63.98 (+0.62)

Charles River (CRL) Beats on Q3 Earnings, Guidance Upped - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 11:30AM CDT
Charles River Laboratories (CRL) reported third-quarter 2014 earnings (excluding special items) of 86 cents per share.
AGN: 195.50 (-0.50), ABBV: 63.85 (+2.35), BMY: 58.69 (+0.37), CRL: 63.98 (+0.62)

Charles River Laboratories raises guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 9:53AM CDT

CRL: 63.98 (+0.62)

Charles River Laboratories International In (CRL) Falls Further As It's Water-Logged And Getting Wetter
at The Street - Thu Oct 30, 9:04AM CDT
Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
CRL: 63.98 (+0.62)

Charles River beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 5:45PM CDT
WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $32 million.
CRL: 63.98 (+0.62)

Ampersand Exits ChanTest Investment
PR Newswire - Wed Oct 29, 3:56PM CDT
Ampersand Capital Partners is pleased to announce the successful sale of Cleveland, Ohio based ChanTest, a leading provider of specialized laboratory testing services for drug development. ChanTest has been acquired by Charles River Laboratories International, Inc. in an all-cash transaction.
CRL: 63.98 (+0.62)

Charles River Laboratories beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 3:30PM CDT

CRL: 63.98 (+0.62)

Charles River Laboratories Announces Third-Quarter 2014 Results from Continuing Operations
Business Wire - Wed Oct 29, 3:06PM CDT
--- Third-Quarter GAAP Earnings per Share of $0.68 and Non-GAAP Earnings per Share of $0.86 -
CRL: 63.98 (+0.62)

Express Scripts Reports In-Line Q3 Earnings, Narrows View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 1:26PM CDT
Express Scripts Holding Company posted third-quarter 2014 earnings per share (excluding special items) of $1.29, in line with the Zacks Consensus Estimate.
AGN: 195.50 (-0.50), ESRX: 77.92 (+0.05), CAH: 78.96 (+0.69), UNH: 94.82 (+1.21), CRL: 63.98 (+0.62)

McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:14AM CDT
McKesson Corporation (MCK) reported fiscal second-quarter 2015 (ended Sep 30, 2014) earnings of $2.79 per share, comfortably beating the Zacks Consensus Estimate of $2.74
AGN: 195.50 (-0.50), MCK: 200.90 (+1.58), CAH: 78.96 (+0.69), CRL: 63.98 (+0.62)

Will Cigna's (CI) Business Diversity Drive Q3 Earnings Beat? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:01PM CDT
We expect Cigna (CI) to give a positive surprise when it reports its earnings on Oct 30, given its Zacks Rank #3 and a positive Earnings ESP.
CI: 101.19 (+2.20), INFI: 13.59 (+0.58), AMAG: 34.96 (+0.01), CRL: 63.98 (+0.62)

Will PerkinElmer (PKI) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:59PM CDT
PerkinElmer (PKI) has managed to perform decently across several product lines and also posted solid operating results in the previous quarter.
HTWR: 78.06 (+1.52), CRL: 63.98 (+0.62), HSIC: 129.39 (+0.55), PKI: 43.97 (+0.16)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:35PM CDT

CSGP: 158.67 (-0.42), CNW: 46.20 (+0.77), ACMP: 62.67 (-0.22), BGC: 14.10 (-0.05), DAC: 6.41 (+0.11), AIZ: 68.00 (+0.03), AEM: 23.08 (-1.53), ESRT: 15.95 (+0.10), CAR: 57.76 (+0.09), CWT: 25.53 (-0.38), AHL: 43.43 (-0.08), CLUB: 6.76 (+0.01), CAVM: 52.85 (-0.22), CJES: 18.85 (-0.29), FB: 75.05 (-0.55), AKAM: 61.11 (+0.98), EXR: 58.62 (+0.40), DWA: 22.04 (-0.20), EXL: 12.95 (+0.10), ANIK: 40.78 (+0.74), CLD: 13.04 (-0.56), ALL: 66.68 (+0.43), DRIV: 24.63 (-0.05), EQIX: 217.52 (+3.49), ESV: 39.79 (-1.52), ASGN: 29.91 (-0.25), AUY: 3.67 (-0.25), ACHC: 60.92 (+0.51), CALX: 11.43 (-0.01), CSII: 29.80 (+0.44), AFOP: 13.66 (+0.16), ARAY: 6.85 (unch), AEGN: 19.58 (+0.30), ATML: 7.57 (+0.13), CENX: 27.16 (-0.98), CUZ: 12.98 (+0.13), CACI: 83.77 (+0.34), ACGL: 57.09 (-0.39), AXS: 49.21 (-0.25), BMR: 21.68 (+0.24), ARII: 68.82 (+2.54), CBG: 31.82 (-0.06), CW: 70.64 (+0.98), DRE: 19.53 (+0.10), ABX: 11.33 (-0.83), CBL: 19.37 (+0.39), CHDN: 103.91 (-0.10), CMO: 12.63 (-0.03), CATM: 37.90 (-0.44), BLKB: 44.71 (-0.11), BIDU: 246.60 (+10.06), EQY: 24.12 (+0.24), ARRS: 30.55 (-0.29), ALDW: 19.34 (+0.36), CRUS: 19.58 (+0.03), CEMP: 13.86 (+0.10), CRL: 63.98 (+0.62)

Why Earnings Season Could Be Great for Charles River Laboratories International (CRL) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 7:57AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and Charles River Laboratories International may be one such company as the firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report
CRL: 63.98 (+0.62)

Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 7:52AM CDT
Charles River Laboratories International could be a great candidate for another beat after a solid performance in the last two quarters.
CRL: 63.98 (+0.62)

Charles River Laboratories Intl (CRL) Stock Research Links

CRL Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Melt Expands with Key Texas Franchise Deal

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

Nonprofit and Partners Gift Homes to Veterans

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

AI Deception Challenges the Confidence of Fraud Defenses

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Choosing the Right Pressure-Treated Lumber for Projects

Diving into the World of Pressure-Treated Lumber John Michael Nixa, the go-to expert from West Side Lumber, has dropped some real nuggets in the world of pressure-treated lumber. This isn't some clickbait headline; it's about making sure your deck or fence doesn't fall apart after the first thunderstorm. Understanding the Lumber Treatment Now, before you run off to the...

Honoring Boston's Architects Changing the Game

Celebrating Architecture's Influencers in Boston Every now and then, a profession needs a wake-up call. Stirring the pot, shaking the roots, call it what you will, but when folks rally together with a shared vision, change doesn't just seem possible — it's inevitable. On November 12, the Boston Society of Architects (BSA) and Architecture in Common (AiC) did just that...

Pine AI Unveils AI Studio & Real-World Call Feature

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Anderson University Sees Financial Turnaround Success

Anderson University, against all odds, is shaking up the financial narrative they’ve been stuck in for a while. It’s kind of like finding a $20 bill in an old coat—a nice surprise but it doesn’t happen every day. The university’s recent report on their financial progress is reminding folks that when it comes to fiscal discipline, sometimes you just need fresh...

Fluence Energy Faces Class Action: Investor Insights

Investor Blues: Fluence Under the Weather If you've been keeping an eye on Fluence Energy (NASDAQ:FLNC), you're probably clutching your metaphorical pearls right now. Here's the scoop: on November 2, 2026, the stock took another nosedive—dropping nearly 9%—as the company announced that both CEO Julian Nebreda and CFO Ahmad Pasha had packed their bags. A leadership...